Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Synthesis and evaluation of aryl-substituted diarylpropionitriles, selective ligands for estrogen receptor beta, as positron-emission tomographic imaging agents.

Moon BS, Carlson KE, Katzenellenbogen JA, Choi TH, Chi DY, Kim JY, Cheon GJ, Koh HY, Lee KC, An G.

Bioorg Med Chem. 2009 May 1;17(9):3479-88. doi: 10.1016/j.bmc.2009.02.064. Epub 2009 Mar 9.

PMID:
19359182
2.

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.

Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.

J Med Chem. 2001 Nov 22;44(24):4230-51.

PMID:
11708925
4.

Indazole estrogens: highly selective ligands for the estrogen receptor beta.

De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA.

J Med Chem. 2005 Feb 24;48(4):1132-44.

PMID:
15715479
5.

Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.

Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.

Biochem Pharmacol. 2006 May 14;71(10):1459-69. Epub 2006 Mar 22.

PMID:
16554039
6.

Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.

Ghosh U, Ganessunker D, Sattigeri VJ, Carlson KE, Mortensen DJ, Katzenellenbogen BS, Katzenellenbogen JA.

Bioorg Med Chem. 2003 Feb 20;11(4):629-57.

PMID:
12538029
7.

Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.

Hsieh RW, Rajan SS, Sharma SK, Guo Y, DeSombre ER, Mrksich M, Greene GL.

J Biol Chem. 2006 Jun 30;281(26):17909-19. Epub 2006 Apr 28.

8.

Structure-based design of estrogen receptor-beta selective ligands.

Manas ES, Unwalla RJ, Xu ZB, Malamas MS, Miller CP, Harris HA, Hsiao C, Akopian T, Hum WT, Malakian K, Wolfrom S, Bapat A, Bhat RA, Stahl ML, Somers WS, Alvarez JC.

J Am Chem Soc. 2004 Nov 24;126(46):15106-19.

PMID:
15548008
9.

Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.

Minutolo F, Bellini R, Bertini S, Carboni I, Lapucci A, Pistolesi L, Prota G, Rapposelli S, Solati F, Tuccinardi T, Martinelli A, Stossi F, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M.

J Med Chem. 2008 Mar 13;51(5):1344-51. doi: 10.1021/jm701396g. Epub 2008 Feb 13.

PMID:
18269232
10.

Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.

Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, Katzenellenbogen JA.

J Med Chem. 2004 Nov 18;47(24):5872-93. Erratum in: J Med Chem. 2005 Apr 7;48(7):2724.

PMID:
15537344
11.

Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor β-selective ligands.

Carroll VM, Jeyakumar M, Carlson KE, Katzenellenbogen JA.

J Med Chem. 2012 Jan 12;55(1):528-37. doi: 10.1021/jm201436k. Epub 2011 Dec 14.

12.

Synthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance target.

Lee JH, Peters O, Lehmann L, Dence CS, Sharp TL, Carlson KE, Zhou D, Jeyakumar M, Welch MJ, Katzenellenbogen JA.

Nucl Med Biol. 2012 Nov;39(8):1105-16. doi: 10.1016/j.nucmedbio.2012.05.011. Epub 2012 Jun 30.

13.
14.

Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.

Hocke C, Prante O, Löber S, Hübner H, Gmeiner P, Kuwert T.

Bioorg Med Chem Lett. 2005 Nov 1;15(21):4819-23.

PMID:
16139501
15.

Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta.

Minutolo F, Antonello M, Bertini S, Rapposelli S, Rossello A, Sheng S, Carlson KE, Katzenellenbogen JA, Macchia M.

Bioorg Med Chem. 2003 Apr 3;11(7):1247-57.

PMID:
12628652
16.

The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.

Wilkening RR, Ratcliffe RW, Tynebor EC, Wildonger KJ, Fried AK, Hammond ML, Mosley RT, Fitzgerald PM, Sharma N, McKeever BM, Nilsson S, Carlquist M, Thorsell A, Locco L, Katz R, Frisch K, Birzin ET, Wilkinson HA, Mitra S, Cai S, Hayes EC, Schaeffer JM, Rohrer SP.

Bioorg Med Chem Lett. 2006 Jul 1;16(13):3489-94. Epub 2006 May 2.

PMID:
16632357
17.

Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.

Shen J, Li W, Liu G, Tang Y, Jiang H.

J Phys Chem B. 2009 Jul 30;113(30):10436-44. doi: 10.1021/jp903785h.

PMID:
19583238
18.

Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.

De Angelis M, Stossi F, Waibel M, Katzenellenbogen BS, Katzenellenbogen JA.

Bioorg Med Chem. 2005 Dec 1;13(23):6529-42. Epub 2005 Aug 15.

PMID:
16099659
19.

Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.

Güngör T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.

J Med Chem. 2006 Apr 20;49(8):2440-55.

PMID:
16610787
20.

Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-alpha selective ligand: [18F] propyl pyrazole triol.

Vijaykumar D, Al-Qahtani MH, Welch MJ, Katzenellenbogen JA.

Nucl Med Biol. 2003 May;30(4):397-404.

PMID:
12767397

Supplemental Content

Support Center